PH25174A - Generic zero order controlles drug delivery system - Google Patents

Generic zero order controlles drug delivery system

Info

Publication number
PH25174A
PH25174A PH37053A PH37053A PH25174A PH 25174 A PH25174 A PH 25174A PH 37053 A PH37053 A PH 37053A PH 37053 A PH37053 A PH 37053A PH 25174 A PH25174 A PH 25174A
Authority
PH
Philippines
Prior art keywords
zero order
controlles
delivery system
drug delivery
generic zero
Prior art date
Application number
PH37053A
Other languages
English (en)
Inventor
Gautam Ramchandra Ranade
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH25174A publication Critical patent/PH25174A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/05—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating specially adapted to be released by contact with a liquid, e.g. for toilets

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Communication Control (AREA)
  • Saccharide Compounds (AREA)
  • Paper (AREA)
  • External Artificial Organs (AREA)
  • Molding Of Porous Articles (AREA)
  • Cephalosporin Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PH37053A 1987-06-11 1988-06-10 Generic zero order controlles drug delivery system PH25174A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/061,925 US4792448A (en) 1987-06-11 1987-06-11 Generic zero order controlled drug delivery system

Publications (1)

Publication Number Publication Date
PH25174A true PH25174A (en) 1991-03-27

Family

ID=22039041

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37053A PH25174A (en) 1987-06-11 1988-06-10 Generic zero order controlles drug delivery system

Country Status (26)

Country Link
US (1) US4792448A (no)
EP (1) EP0294993B1 (no)
JP (1) JPH0688900B2 (no)
KR (1) KR900004092B1 (no)
CN (1) CN1018151B (no)
AT (1) ATE64850T1 (no)
AU (1) AU598938B2 (no)
CA (1) CA1326821C (no)
CS (1) CS274431B2 (no)
DD (1) DD284599A5 (no)
DE (1) DE3863493D1 (no)
DK (1) DK175285B1 (no)
EG (1) EG18919A (no)
ES (1) ES2022988B3 (no)
FI (1) FI94025C (no)
GR (1) GR3002260T3 (no)
IE (1) IE61123B1 (no)
IL (1) IL86631A (no)
MY (1) MY101285A (no)
NO (1) NO176162C (no)
NZ (1) NZ224981A (no)
PH (1) PH25174A (no)
PT (1) PT87701B (no)
RU (1) RU2072835C1 (no)
YU (1) YU46569B (no)
ZA (1) ZA884163B (no)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US4981870A (en) * 1989-03-07 1991-01-01 Pfizer Inc. Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
US6361795B1 (en) * 1989-09-05 2002-03-26 Alza Corporation Method for lowering blood glucose
US5591454A (en) * 1989-09-05 1997-01-07 Alza Corporation Method for lowering blood glucose
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5343550A (en) * 1993-02-25 1994-08-30 The United States Of America As Represented By The United States National Aeronautics And Space Administration Transversely polarized source cladding for an optical fiber
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
MX9605419A (es) * 1994-05-06 1997-12-31 Pfizer Formas de dosificacion de liberacion controlada de azitromicina.
US5534263A (en) 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US6224905B1 (en) 1996-06-17 2001-05-01 Janssen Pharmaceutica N.V. Biconvex rapidly disintegrating dosage forms
ES2322405T3 (es) 1996-07-08 2009-06-19 Penwest Pharmaceuticals Co. Matriz de liberacion controlada para farmacos insolubles en dosis elevadas.
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
NZ501251A (en) 1997-07-01 2001-09-28 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
ATE285226T1 (de) * 1997-08-11 2005-01-15 Alza Corp Gastrische zurückhalteform zur verlängerten freisetzung eines wirkstoffs
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6365183B1 (en) 1998-05-07 2002-04-02 Alza Corporation Method of fabricating a banded prolonged release active agent dosage form
AU762291B2 (en) * 1999-09-30 2003-06-19 Penwest Pharmaceutical Co. Sustained release matrix systems for highly soluble drugs
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6837696B2 (en) 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
BR0212950A (pt) 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas tendo uma porção inserida
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
JP2005526104A (ja) 2002-04-04 2005-09-02 ファイザー・プロダクツ・インク 味の良い咀嚼可能な錠剤
CN100435880C (zh) * 2003-02-28 2008-11-26 微创医疗器械(上海)有限公司 一种药物洗脱介入医疗器械及其制备方法
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
JP3811127B2 (ja) * 2003-01-30 2006-08-16 株式会社東芝 情報記録装置及び情報記録方法
EP1691789B1 (en) * 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
MXPA06006810A (es) * 2003-12-17 2006-08-23 Pfizer Prod Inc Tratamiento de afecciones que se presentan con un nivel bajo de masa osea por terapia de combinacion continua con agonistas selectivos del receptor de prostaglandina ep4 y un estrogeno.
US9492541B2 (en) * 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
US8541028B2 (en) 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
CA2596933A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
AU2006226742A1 (en) * 2005-03-24 2006-09-28 E. I. Du Pont De Nemours & Company Transponder overmolded with ethylene copolymers
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
EP1859788A1 (en) * 2006-05-24 2007-11-28 Abbott GmbH & Co. KG Production of enveloped pharmaceutical dosage forms
EP2111788B1 (en) * 2007-01-30 2014-01-08 Olympus Medical Systems Corp. Device for checking for lumen passage
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
CA2775079A1 (en) * 2009-09-22 2011-03-31 Evonik Degussa Corporation Implant devices for modulating bioactive agent release profiles
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
JP5879979B2 (ja) 2011-11-30 2016-03-08 ブラザー工業株式会社 分離片ユニットおよびシート搬送装置
GB2498999A (en) 2012-02-02 2013-08-07 Siemens Plc Mechanical superconducting switch
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
USD765828S1 (en) 2015-02-19 2016-09-06 Crossford International, Llc Chemical tablet
USD789514S1 (en) * 2016-06-01 2017-06-13 David Hill Injectable tablet
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CA3242369A1 (en) * 2016-07-19 2018-01-25 Johnson & Johnson Consumer Inc. (A Delaware Corporation) Tablets having discontinuous coated regions
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
MX2020012459A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
AU2019275406A1 (en) 2018-05-24 2020-07-16 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
AU2021217209A1 (en) 2020-02-03 2022-09-29 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine
DK4037666T3 (da) 2020-12-08 2024-06-24 Ruminant Biotech Corp Ltd Forbedring af anordninger og fremgangsmåder til indgivelse af substanser til dyr
USD979043S1 (en) * 2021-04-29 2023-02-21 Kurt A. Van Tine Tablet

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2539036A (en) * 1946-04-25 1951-01-23 Schwab Fritz Arrangement for applying chemicals and minerals for therapeutical purposes
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
CH569482A5 (no) * 1970-12-23 1975-11-28 Boehringer Sohn Ingelheim
AT341100B (de) * 1972-12-27 1978-01-25 Alza Corp Verfahren zur herstellung eines korpers bzw. einer vorrichtung zur abgabe mit gesteuerter geschwindigkeit eines aktiven mittels
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
CH646330A5 (en) * 1980-05-21 1984-11-30 Ciba Geigy Ag Divisible slow-release pharmaceutical tablets
AU8363582A (en) * 1981-06-15 1982-12-23 Bally Manufacturing Corp. Surface projectile game
GB2110524B (en) * 1981-12-05 1985-06-12 Ronald Poppleton Hill Apparatus for dispensing a volatile material
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
IN162525B (no) * 1984-02-08 1988-06-04 Pfizer
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems
GB8514666D0 (en) * 1985-06-11 1985-07-10 Coopers Animal Health Agent delivery systems
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation

Also Published As

Publication number Publication date
JPH0688900B2 (ja) 1994-11-09
CS274431B2 (en) 1991-04-11
KR900004092B1 (ko) 1990-06-15
CA1326821C (en) 1994-02-08
DK318788D0 (da) 1988-06-10
NZ224981A (en) 1991-07-26
NO176162C (no) 1995-02-15
CN1018151B (zh) 1992-09-09
EG18919A (en) 1994-06-30
IL86631A0 (en) 1988-11-30
FI882780A (fi) 1988-12-12
GR3002260T3 (en) 1992-12-30
KR890000081A (ko) 1989-03-11
DK175285B1 (da) 2004-08-09
AU1761488A (en) 1988-12-15
EP0294993B1 (en) 1991-07-03
NO882565D0 (no) 1988-06-10
NO176162B (no) 1994-11-07
IE881763L (en) 1988-12-11
US4792448A (en) 1988-12-20
IL86631A (en) 1991-09-16
YU112688A (en) 1990-04-30
PT87701A (pt) 1988-07-01
FI94025B (fi) 1995-03-31
RU2072835C1 (ru) 1997-02-10
FI882780A0 (fi) 1988-06-10
ZA884163B (en) 1990-02-28
DE3863493D1 (de) 1991-08-08
ES2022988B3 (es) 1991-12-16
FI94025C (fi) 1995-07-10
MY101285A (en) 1991-08-17
CN1030358A (zh) 1989-01-18
YU46569B (sh) 1993-11-16
AU598938B2 (en) 1990-07-05
DD284599A5 (de) 1990-11-21
EP0294993A1 (en) 1988-12-14
IE61123B1 (en) 1994-10-05
DK318788A (da) 1989-02-06
CS401188A2 (en) 1990-08-14
PT87701B (pt) 1992-09-30
ATE64850T1 (de) 1991-07-15
JPS649930A (en) 1989-01-13
NO882565L (no) 1988-12-12

Similar Documents

Publication Publication Date Title
EG18919A (en) A generic zero order controlled drug delivery system
PT88854A (pt) Sistema para a libertacao controlada dum medicamento benefico
EP0237159A3 (en) 2 stage drug delivery device 2 stage drug delivery device
FI873822A (fi) Väline vaikuttavan aineen vapauttamiseksi kontrolloidusti ja menetelmä sen valmistamiseksi
GB2140309B (en) Fluid handling system for medication infusion system
ES8801114A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
KR890701165A (ko) 유익한 약품을 정맥내 수액 시스템내에 도입하기 위한 약품통과 연접기
PT97203A (pt) Sistema de dosagem osmotica para libertacao de farmacos liquidos
NZ239574A (en) Delayed release capsules having a permeable wall with a hole and containing fluid-expandable material which pushes out first an inert substance then a drug-containing material
IL69431A0 (en) Liquid delivery system particularly useful as an implantable micropump for delivering insulin or other drugs
IT1216533B (it) Struttura di supporto per un cuscinetto di un sistema a slitta di precisione.
IL101445A (en) Ambulatory fluid delivery system
IT8720708A0 (it) Sistema terapeutico per la cessione controllata di farmaci.
IT8816916A0 (it) Sistema nebulizzatore per fluidi privo di gas propellenti
BR6700425U (pt) Metodo de um sistema de abastecimento de materiais que possuem a capacidade do escoamento